From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Rivaroxaban is a novel oral anticoagulant (NOAC) drug and a Factor Xa inhibitor, which is sold under the brand name Xarelto.[1]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Rivaroxaban Uses, Side Effects & Warnings". Drugs.com. Retrieved August 2, 2022.